Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997 Sep;17(9):526-30.

[Clinical study of bugu shengsui capsule in treating primary osteoporosis with kidney-yang deficiency syndrome]

[Article in Chinese]
Y M Xie  1 , F Z Zhang, W Q Zhou
Affiliations
  • PMID: 10322872
Clinical Trial

[Clinical study of bugu shengsui capsule in treating primary osteoporosis with kidney-yang deficiency syndrome]

[Article in Chinese]
Y M Xie et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 Sep.

Abstract

Objective: To assess the effect of Bugu Shengsui capsule (BGSSC) in treating primary osteoporosis.

Methods: Using double energy X-ray bone densimeter and radioimmunoassay (RIA), the effect of BGSSC in treating primary osteoporosis (OP) with Kidney-Yang Deficiency syndrome.

Results: The clinical markedly effective and total effective rates of BGSSC were 46% and 82%, respectively. The rate of TCM group is significantly higher than that of the control group (Vitamin D plus calcium). BGSSC could improve bone mineral density by the verification of double energy X-ray bone dansity (DEXA). It could also increase the level of serum calcitonin, luteinizing hormone and calcium, decrease the activity of parathyroid hormone.

Conclusions: The effects of BGSSC on primary OP included increasing patient's bone mineral density, depressing bone resorption and decreasing bone loss.

PubMed Disclaimer

Publication types

LinkOut - more resources